Nonprosthesis Orthopedic Applications of 18F Fluoro-2-Deoxy-d-Glucose PET in the Detection of Osteomyelitis

PET Clinics

Volumn 1, Issue 2, 2006, Pages 107-121

  Meller, Johannes ^a   Sahlmann, Carsten Oliver ^a   Liersch, Torsten ^a   Tang, Peter Hao ^b   Alavi, Abass ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 64749104577     PISSN: 15568598     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpet.2006.01.004     Document Type: Review

References (59)

1. Lew D.P., and Waldvogel F.A. Osteomyelitis. N Engl J Med 336 14 (1997) 999-1007
2. Lew D.P., and Waldvogel F.A. Osteomyelitis. Lancet 364 9431 (2004) 369-379
3. Waldvogel F.A., Medoff G., and Swartz M.N. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med 282 4 (1970) 316-322
4. Waldvogel F.A., and Vasey H. Osteomyelitis: the past decade. N Engl J Med 303 7 (1980) 360-371
5. Mader J.T., Shirtliff M., and Calhoun J.H. Staging and staging application in osteomyelitis. Clin Infect Dis 25 6 (1997) 1303-1309
6. Becker W. Imaging osteomyelitis and the diabetic foot. Q J Nucl Med 43 1 (1999) 9-20
7. Schauwecker D.S. The scintigraphic diagnosis of osteomyelitis. AJR Am J Roentgenol 158 1 (1992) 9-18
8. Shepherd P.R., and Kahn B.B. Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus. N Engl J Med 341 4 (1999) 248-257
9. Sokoloff L., Reivich M., Kennedy C., et al. The (14C) deoxyglucose method for the measurement of local cerebral glucose utilisation: theory, procedure and normal values in the conscious and anesthetized albino rat. J Neurochem 28 6 (1977) 897-916
10. Pauwels E.K., Sturm E.J., Bombardieri E., et al. Positron-emission tomography with fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies. J Cancer Res Clin Oncol 126 10 (2000) 549-559
11. Stahl A., Weber W.A., Avril N., et al. Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen. Nuklearmedizin 39 8 (2000) 241-245
12. Baldwin S.A., Kan O., Whetton A.D., et al. Regulation of the glucose transporter GUT1 in mammalian cells. Biochem Soc Trans 22 3 (1994) 814-817
13. von Schulthess G.K., Stumpe K.D.M., and Engel-Bicik I. Clinical PET imaging of inflammatory diseases. In: von Schulthess G.K. (Ed). Clinical positron emission tomography (PET) (2000), Lippincott Williams & Wilkins, Philadelphia 229-248
14. Tahara T., Ichiya Y., Kuwabara Y., et al. High-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr 13 5 (1989) 829-831
15. Becker W., and Meller J. The role of nuclear medicine in infection and inflammation. Lancet Infect Dis 1 1 (2001) 326-333
16. Osman S., and Danpure H.J. The use of 2-fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography. Int J Radiat Appl Instrum 19 2 Pt B (1992) 183-190
17. 18F-FDG labelling of human leucocytes. Nucl Med Commun 21 7 (2000) 691-694
18. Lehmann K., Meller J., Behe M., et al. F-18-FDG uptake in granulozyten: basis der F-18-FDG szintigraphie. Nuklearmedizin 40 3 (2001) V168 [in German]
19. Kubota R., Yamada S., Kubota K., et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulocytes studied by microautoradiography. J Nucl Med 33 7 (1992) 1972-1980
20. Jones H.A., Sriskandan S., Peters A.M., et al. Dissociation of neutrophil emigration and metabolic activity in lobar pneumonia and bronchiectasis. Eur Respir J 10 4 (1997) 795-803
21. Ishimori T., Saga T., Mamede M., et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med 43 5 (2002) 658-663
22. Sugawara Y., Gutowski T.D., Fisher S.J., et al. Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, 67Ga-citrate, and 125I-HSA. Eur J Nucl Med 26 4 (1999) 333-341
23. Gould G.W., and Holman G.D. The glucose transporter family: structure, function and tissue-specific expression. Biochem J 295 (1993) 329-341
24. Gamelli R.L., Liu H., He L.K., et al. Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice. J Leukoc Biol 59 5 (1996) 639-647
25. Fukuzumi M., Shinomiya H., Shimizu Y., et al. Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via GLUT1. Infect Immun 64 1 (1996) 108-112
26. Malide D., Davies-Hill T.M., Levine M., et al. Distinct localisation of GLUT-1 and -5 in human monocyte-derived macrophages: effects of cell activation. Am J Physiol 274 3 Pt 1 (1998) E516-E526
27. Chakrabarti R., Jung C.Y., Lee T.P., et al. Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin. J Immunol 152 6 (1994) 2660-2668
28. Mamede M., Higashi T., Kitaichi M., et al. FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia 7 4 (2005) 369-379
29. Jacobs D.B., Lee T.P., Jung C.Y., et al. Mechanism of mitogen-induced stimulation of glucose transport in human peripheral blood mononuclear cells. J Clin Invest 83 2 (1989) 437-443
30. Pekala P., Marlow M., Heuvelman D., et al. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J Biol Chem 265 30 (1990) 18051-18054
31. Cornelius P., Marlowe M., and Pekala P.H. Regulation of glucose transport by tumor necrosis factor-α in cultured murine 3T3-L1 fibroblasts. J Trauma 30 12 Suppl (1990) S15-S20
32. Tan A.S., Ahmed N., and Berridge M.V. Acute regulation of glucose transport after activation of human peripheral blood neutrophils by phorbol myristate acetate, fMLP, and granulocyte-macrophage colony-stimulating factor. Blood 91 2 (1998) 649-655
33. Bird T.A., Davies A., Baldwin S.A., et al. Interleukin 1 stimulates hexose transport in fibroblasts by increasing the expression of glucose transporters. J Biol Chem 265 23 (1990) 13578-13583
34. Ahmed N., Kansara M., and Berridge M.V. Acute regulation of glucose transport in a monocyte-macrophage cell line: Glut-3 affinity for glucose is enhanced during the respiratory burst. Biochem J 327 (1997) 369-375
35. Mochizuki T., Tsukamoto E., Kuge Y., et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med 42 10 (2001) 1551-1555
36. Zhao S., Kuge Y., Tsukamoto E., et al. Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: effects of insulin and glucose loading. Nucl Med Commun 23 6 (2002) 545-550
37. Zhuang H.M., Cortes-Blanco A., Pourdehnad M., et al. Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders?. Nucl Med Commun 22 10 (2001) 1123-1128
38. Einhorn T.A. The cell and molecular biology of fracture healing. Clin Orthop 355 Suppl (1998) S7-S21
39. Jones-Jackson L., Walker R., Purnell G., et al. Early detection of bone infection and differentiation from post-surgical inflammation using 2-deoxy-2-[(18)F]-fluoro-d-glucose positron emission tomography (FDG PET) in an animal model. J Orthop Res 23 6 (2005) 1484-1489
40. Koort J.K., Makinen T.J., Knuuti J., et al. Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing. J Nucl Med 45 8 (2004) 1406-1411
41. de Winter F., Van de Wiele C., Vandenberghe S., et al. Coincidence camera FDG imaging for the diagnosis of chronic orthopedic infections: a feasibility study. J Comput Assist Tomogr 25 2 (2001) 184-189
42. de Winter F., van de Wiele C., Vogelaers D., et al. Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 83 5 (2001) 651-660
43. de Winter F., Gemme F., Van De Wiele C., et al. 18-Fluorine fluorodeoxyglucose positron emission tomography for the diagnosis of infection in the postoperative spine. Spine 28 12 (2003) 1314-1319
44. Meller J., Köster G., Liersch T., et al. Chronic bacterial osteomyelitis-prospective comparison of 18 FDG-imaging with a double head coincidence camera (DHCC) and In-111 labeled autologous leucocytes. Eur J Nucl Med 29 1 (2002) 53-60
45. Meller J., Sahlmann C.O., Lehmann K., et al. F-18-FDG hybrid camera PET in patients with postoperative fever. Nuklearmedizin 41 1 (2001) 22-29
46. Meller J., Siefker U., and Becker W. Nuklearmedizinische Diagnostik erregerbedingter Skeletterkrankungen [Scientific diagnosis of bacterial skeletal diseases]. Nuklearmedizin 25 2 (2002) 122-132 [in German]
47. Gratz S., Dörner J., Fischer U., et al. 18F-FDG hybrid PET in patients with suspected spondylitis. Eur J Nucl Med 29 4 (2002) 516-524
48. Zhuang H., Duarte P.S., Pourdehand M., et al. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med 25 4 (2000) 281-284
49. Zhuang H., Sam J.W., Chacko T.K., et al. Rapid normalization of osseous FDG uptake following traumatic or surgical fractures. Eur J Nucl Med Mol Imaging 30 8 (2003) 1096-1103
50. Schmitz A., Risse J.H., Textor J., et al. FDG PET findings of vertebral compression fractures in osteoporosis: preliminary results. Osteoporos Int 13 9 (2002) 755-761
51. Kälicke T., Schmitz A., Risse J.H., et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med 27 5 (2000) 524-528
52. Kaim A., Ledermann H.P., Bongartz G., et al. Chronic post-traumatic osteomyelitis of the lower extremity: comparison of magnetic resonance imaging and combined bone scintigraphy/immunoscintigraphy with radiolabelled monoclonal antigranulocyte antibodies. Skeletal Radiol 29 7 (2000) 378-386
53. Kaim A.H., Gross T., and von Schulthess G.K. Imaging of chronic posttraumatic osteomyelitis. Eur Radiol 13 7 (2003) 1750-1752
54. Guhlmann A., Brecht Krauss D., Suger G., et al. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med 39 12 (1998) 2145-2152
55. Guhlmann A., Brecht-Krauss D., Suger G., et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 206 3 (1998) 749-754
56. Schmitz A., Risse J.H., Grunwald F., et al. Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results. Eur Spine J 10 6 (2001) 534-539
57. 18F]FDG)-PET in chronic bacterial osteomyelitis (COM). Nucl Med Commun 25 8 (2004) 819-823
58. Robiller F.C., Stumpe K.D., Kossmann T., et al. Chronic osteomyelitis of the femur: value of PET imaging. Eur Radiol 10 5 (2000) 855-858
59. Siefker U., Sahlmann C.O., Lehmann K., et al. F-18-FDG PET im Vergleich zur MRT bei der Primärdiagnostik und postoperativen Kontrolle bei chronischer bakterieller Osteomyelitis (COM). Nuklearmedizin 43 3 (2004) V116 [in German]